felbamate has been researched along with Absence Seizure Disorder in 1 studies
Felbamate: A PEGylated phenylcarbamate derivative that acts as an antagonist of NMDA RECEPTORS. It is used as an anticonvulsant, primarily for the treatment of SEIZURES in severe refractory EPILEPSY.
felbamate : The bis(carbamate ester) of 2-phenylpropane-1,3-diol. An anticonvulsant, it is used in the treatment of epilepsy.
Excerpt | Relevance | Reference |
---|---|---|
" PTZ test was influenced by meprobamate in a fairly low dosage (ED50 66 mg/kg), but for felbamate no clearly dose-related effect could be shown up to 150 mg/kg." | 1.30 | Felbamate and meprobamate: a comparison of their anticonvulsant properties. ( Bartels, I; Frey, HH, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frey, HH | 1 |
Bartels, I | 1 |
1 other study available for felbamate and Absence Seizure Disorder
Article | Year |
---|---|
Felbamate and meprobamate: a comparison of their anticonvulsant properties.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Electroshock; Epilepsy, Absence; Felbamate; Female | 1997 |